These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


542 related items for PubMed ID: 16567675

  • 1. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [Abstract] [Full Text] [Related]

  • 2. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
    Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF.
    J Comput Assist Tomogr; 2008 Mar; 32(3):347-52. PubMed ID: 18520535
    [Abstract] [Full Text] [Related]

  • 3. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H, Harman M, Cinar C, Bozkaya H, Parildar M, Elmas N.
    J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 7. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.
    Kamel IR, Reyes DK, Liapi E, Bluemke DA, Geschwind JF.
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):49-56. PubMed ID: 17296704
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ, Zhang L, Ouyang YS.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2474-7. PubMed ID: 19080627
    [Abstract] [Full Text] [Related]

  • 9. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec 16; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver.
    Youn BJ, Chung JW, Son KR, Kim HC, Jae HJ, Lee JM, Song IC, Kim IO, Park JH.
    Acad Radiol; 2008 May 16; 15(5):593-600. PubMed ID: 18423316
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA.
    Murakami T, Nakamura H, Hori S, Tomoda K, Mitani T, Nakanishi K, Hashimoto T, Tsuda K, Kozuka T, Monden M.
    Acta Radiol; 1993 Jul 16; 34(4):399-403. PubMed ID: 8391291
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC.
    J Magn Reson Imaging; 2004 May 16; 19(5):598-604. PubMed ID: 15112309
    [Abstract] [Full Text] [Related]

  • 17. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
    Yu JS, Kim JH, Chung JJ, Kim KW.
    J Magn Reson Imaging; 2009 Jul 16; 30(1):153-60. PubMed ID: 19557734
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M, Haas S, Loehr M, Elshwi M, Singer MV, Brade J, Schoenberg SO, Diehl SJ.
    Onkologie; 2010 Jul 16; 33(1-2):31-7. PubMed ID: 20164659
    [Abstract] [Full Text] [Related]

  • 20. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M.
    Invest Radiol; 2006 Aug 16; 41(8):618-23. PubMed ID: 16829744
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.